BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 11180082)

  • 21. Modified cancer TNM classification for localized renal cell carcinoma based on the prognostic analysis of 3748 cases from a single center.
    Zhang J; Li X; Lin J; Liu Z; Tian Y; Wang Q
    Can J Physiol Pharmacol; 2022 Jan; 100(1):5-11. PubMed ID: 34779659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reassessment of the 1997 TNM classification system for renal cell carcinoma.
    Elmore JM; Kadesky KT; Koeneman KS; Sagalowsky AI
    Cancer; 2003 Dec; 98(11):2329-34. PubMed ID: 14635066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of the revised Tumour Node Metastasis (TNM) staging system of clear cell renal cell carcinoma in eastern China: advantages and limitations.
    Qin C; Sun LJ; Cui L; Cao Q; Zhu J; Li P; Zhang GM; Mao X; Shao PF; Wang ML; Zhang ZD; Gu M; Zhang W; Yin CJ
    Asian J Androl; 2013 Jul; 15(4):550-7. PubMed ID: 23564046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of tumor size on the long-term survival of patients with early stage renal cell cancer.
    Kuczyk M; Wegener G; Merseburger AS; Anastasiadis A; Machtens S; Zumbrägel A; Hartmann JT; Bokemeyer C; Jonas U; Stenzl A
    World J Urol; 2005 Feb; 23(1):50-4. PubMed ID: 15729558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of tumour size in patients after tumour nephrectomy for localised renal cell carcinoma.
    Steiner T; Knels R; Schubert J
    Eur Urol; 2004 Sep; 46(3):327-30. PubMed ID: 15306102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of imaging modalities, staging systems, and prognostic indicators for renal cell carcinoma.
    Dinney CP; Awad SA; Gajewski JB; Belitsky P; Lannon SG; Mack FG; Millard OH
    Urology; 1992 Feb; 39(2):122-9. PubMed ID: 1736503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Redefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system.
    Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
    Cancer; 2007 Jun; 109(12):2439-44. PubMed ID: 17487856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of tumor size on the clinical outcomes of patients with Robson State I renal cell carcinoma.
    Kinouchi T; Saiki S; Meguro N; Maeda O; Kuroda M; Usami M; Kotake T
    Cancer; 1999 Feb; 85(3):689-95. PubMed ID: 10091742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the 1997 tumour, nodes and metastases classification of renal cell carcinoma: experience in 172 patients.
    Minervini R; Minervini A; Fontana N; Traversi C; Cristofani R
    BJU Int; 2000 Aug; 86(3):199-202. PubMed ID: 10930914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new staging system for locally advanced (pT3-4) renal cell carcinoma: a multicenter European study including 2,000 patients.
    Ficarra V; Galfano A; Guillé F; Schips L; Tostain J; Mejean A; Lang H; Mulders P; De La Taille A; Chautard D; Descotes JL; Cindolo L; Novara G; Rioux-Leclercq N; Zattoni F; Artibani W; Patard JJ
    J Urol; 2007 Aug; 178(2):418-24; discussion 423-4. PubMed ID: 17561128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.
    Klatte T; Patard JJ; Goel RH; Kleid MD; Guille F; Lobel B; Abbou CC; De La Taille A; Tostain J; Cindolo L; Altieri V; Ficarra V; Artibani W; Prayer-Galetti T; Allhoff EP; Schips L; Zigeuner R; Figlin RA; Kabbinavar FF; Pantuck AJ; Belldegrun AS; Lam JS
    J Urol; 2007 Jul; 178(1):35-40; discussion 40. PubMed ID: 17521678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinoma.
    Brookman-May S; May M; Zigeuner R; Shariat SF; Scherr DS; Chromecki T; Moch H; Wild PJ; Mohamad-Al-Ali B; Cindolo L; Wieland WF; Schips L; De Cobelli O; Rocco B; Santoro L; De Nunzio C; Tubaro A; Coman I; Feciche B; Truss M; Dalpiaz O; Hohenfellner M; Gilfrich C; Wirth MP; Burger M; Pahernik S;
    J Urol; 2011 Dec; 186(6):2175-81. PubMed ID: 22014800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T3b the same?
    Moinzadeh A; Libertino JA
    J Urol; 2004 Feb; 171(2 Pt 1):598-601. PubMed ID: 14713768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Risk factors for recurrence in pT3aN0M0 renal cell carcinoma according to 2009 TNM classification].
    Utsunomiya N; Kono Y; Matsumoto K; Sumiyoshi T; Masuda N; Shiraishi Y; Negoro H; Tsunemori H; Sugino Y; Okubo K; Okada T; Segawa T; Muguruma K; Kawakita M
    Hinyokika Kiyo; 2014 Jan; 60(1):1-5. PubMed ID: 24594765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan.
    Minagawa M; Ikai I; Matsuyama Y; Yamaoka Y; Makuuchi M
    Ann Surg; 2007 Jun; 245(6):909-22. PubMed ID: 17522517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].
    Shi GD; Luo ZL; Fu MY; Tian D; Zhang L; Zhang KP
    Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):916-21. PubMed ID: 25623766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?
    Brookman-May SD; May M; Wolff I; Zigeuner R; Hutterer GC; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Tubaro A; Coman I; Truss M; Dalpiaz O; Feciche B; Figenshau RS; Madison K; Sánchez-Chapado M; Santiago Martin Mdel C; Salzano L; Lotrecchiano G; Zastrow S; Wirth M; Sountoulides P; Shariat S; Waidelich R; Stief C; Gunia S; ;
    Eur Urol; 2015 May; 67(5):943-51. PubMed ID: 25684695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proposal of an improved prognostic classification for pT3 renal cell carcinoma.
    Terrone C; Gontero P; Volpe A; Porpiglia F; Bollito E; Zattoni F; Frea B; Tizzani A; Fontana D; Scarpa RM; Rossetti SR
    J Urol; 2008 Jul; 180(1):72-8. PubMed ID: 18485380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal cell carcinoma invading the urinary collecting system: implications for staging.
    Uzzo RG; Cherullo E; Myles J; Novick AC
    J Urol; 2002 Jun; 167(6):2392-6. PubMed ID: 11992044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.